These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 16030154)

  • 1. Effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men.
    Matthiesson KL; Stanton PG; O'Donnell L; Meachem SJ; Amory JK; Berger R; Bremner WJ; McLachlan RI
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5647-55. PubMed ID: 16030154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist.
    Matthiesson KL; Amory JK; Berger R; Ugoni A; McLachlan RI; Bremner WJ
    J Clin Endocrinol Metab; 2005 Jan; 90(1):91-7. PubMed ID: 15509637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin suppression in men leads to a reduction in claudin-11 at the Sertoli cell tight junction.
    McCabe MJ; Tarulli GA; Laven-Law G; Matthiesson KL; Meachem SJ; McLachlan RI; Dinger ME; Stanton PG
    Hum Reprod; 2016 Apr; 31(4):875-86. PubMed ID: 26908839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.
    McLachlan RI; O'Donnell L; Stanton PG; Balourdos G; Frydenberg M; de Kretser DM; Robertson DM
    J Clin Endocrinol Metab; 2002 Feb; 87(2):546-56. PubMed ID: 11836283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
    Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional role of progestin and the progesterone receptor in the suppression of spermatogenesis in rodents.
    Lue Y; Wang C; Lydon JP; Leung A; Li J; Swerdloff RS
    Andrology; 2013 Mar; 1(2):308-17. PubMed ID: 23408752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis.
    Wang C; Cui YG; Wang XH; Jia Y; Sinha Hikim A; Lue YH; Tong JS; Qian LX; Sha JH; Zhou ZM; Hull L; Leung A; Swerdloff RS
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3292-304. PubMed ID: 17504903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct effect of progestogen on gene expression in the testis during gonadotropin withdrawal and early suppression of spermatogenesis.
    Walton MJ; Bayne RA; Wallace I; Baird DT; Anderson RA
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2526-33. PubMed ID: 16621906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.
    Anawalt BD; Bebb RA; Bremner WJ; Matsumoto AM
    J Androl; 1999; 20(3):407-14. PubMed ID: 10386821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
    Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM
    J Androl; 2005; 26(3):405-13. PubMed ID: 15867009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen.
    Coviello AD; Bremner WJ; Matsumoto AM; Herbst KL; Amory JK; Anawalt BD; Yan X; Brown TR; Wright WW; Zirkin BR; Jarow JP
    J Androl; 2004; 25(6):931-8. PubMed ID: 15477366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative roles of follicle-stimulating hormone and luteinizing hormone in maintaining spermatogonial maturation and spermiation in normal men.
    Matthiesson KL; McLachlan RI; O'Donnell L; Frydenberg M; Robertson DM; Stanton PG; Meachem SJ
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3962-9. PubMed ID: 16895950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereological evaluation of human spermatogenesis after suppression by testosterone treatment: heterogeneous pattern of spermatogenic impairment.
    Zhengwei Y; Wreford NG; Royce P; de Kretser DM; McLachlan RI
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1284-91. PubMed ID: 9543157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratesticular androgens and spermatogenesis during severe gonadotropin suppression induced by male hormonal contraceptive treatment.
    Page ST; Kalhorn TF; Bremner WJ; Anawalt BD; Matsumoto AM; Amory JK
    J Androl; 2007; 28(5):734-41. PubMed ID: 17494097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone-dependent restoration of spermatogenesis in adult rats is impaired by a 5alpha-reductase inhibitor.
    O'Donnell L; Pratis K; Stanton PG; Robertson DM; McLachlan RI
    J Androl; 1999; 20(1):109-17. PubMed ID: 10100481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse model of male germ cell apoptosis in response to a lack of hormonal stimulation.
    Hikim AP; Vera Y; Elhag RI; Lue Y; Cui YG; Pope V; Leung A; Atienza V; Wang C; Swerdloff RS
    Indian J Exp Biol; 2005 Nov; 43(11):1048-57. PubMed ID: 16315394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.